Jupiter Life Line Hospitals Ltd| Audited Consolidated Financial Results – Q4 & FY 2025-26

⬤25th Jun 26

Summary : Jupiter Life Line Hospitals reports stable profits, significant capex, and a share split for enhanced liquidity.

Quarterly Report Analysis & Insights

Financial Disclosures

Consolidated finance costs increased to Rs. 326.63 million (FY26) from Rs. 107.06 million (FY25).
Consolidated depreciation and amortisation increased to Rs. 876.40 million (FY26) from Rs. 570.83 million (FY25).
Exceptional item of Rs. 48.87 million (consolidated) due to gratuity liability.
Consolidated trade receivables increased to Rs. 755.39 million (FY26).
Standalone trade receivables increased to Rs. 671.39 million (FY26).
Consolidated revenue from operations: Rs. 14,997.87 million (FY26).
Standalone revenue from operations: Rs. 11,976.24 million (FY26).
Consolidated net cash generated from operating activities remained stable at Rs. 2,677.08 million (FY26).
Consolidated net cash used in investing activities was Rs. (4,419.32) million (FY26), indicating significant capex.
Consolidated net cash from financing activities decreased to Rs. 1,364.69 million (FY26).
Overall decrease in consolidated cash and cash equivalents by Rs. 377.55 million (FY26).
Consolidated Property, Plant & Equipment increased to Rs. 12,768.59 million (FY26) from Rs. 8,994.19 million (FY25).
Consolidated total assets increased to Rs. 23,831.29 million (FY26) from Rs. 19,357.50 million (FY25).
Consolidated non-current borrowings increased to Rs. 5,008.97 million (FY26) from Rs. 3,217.45 million (FY25).
Consolidated cash and cash equivalents decreased to Rs. 547.61 million (FY26) from Rs. 925.16 million (FY25).
Dr. Ajay Thakker (Chairman) is father of Dr. Ankit Thakker (MD & CEO).
Both standalone and consolidated results show revenue growth and stable net profits.
Both reflect significant capital expenditure and increased borrowings.
Consolidated results include financial performance of subsidiaries and partnership firms.

Corporate Overview

Operations primarily in India, with offices in Mumbai, Thane, and Pune.
Impact of new Labour Codes on gratuity liability, treated as an exceptional item.
Primarily engaged in healthcare services in India.
Leadership emphasizes compliance with regulations and strategic growth.
Focus on operational efficiency and patient care delivery.
Healthcare services constitute the only reportable business segment.
Hotel division is not a reportable segment due to low contribution.
Significant increase in Property, Plant & Equipment (PPE) indicates capacity expansion.
Significant capital expenditure on Property, Plant & Equipment and Capital Work-in-Progress.
Payments for acquiring PPE, CWIP, and intangibles increased substantially.

Risk Factors

Increased finance costs due to borrowings
Impact of new labor codes on liabilities
Pending NCLT approval for merger
Decreased cash and cash equivalents

Key Drivers

Share split to enhance liquidity
Significant capital expenditure for growth
Stable net profit and revenue growth
Strategic appointments for operational excellence

Auditor’s Report

Unmodified opinion on both standalone and consolidated financial results.
Reliance on reports of other auditors for subsidiaries and partnership firms.

Board Commentary

Dr. Ajay Thakker's designation changed to Chairman & Whole-time Director.
Mr. Aditya Gupta appointed as Senior Vice President – Corporate Affairs.
Dr. Tushar Patil appointed as Head Operations, Dombivli.
Varma & Varma reappointed as Internal Auditor for FY 2026-27.
M/s V.J. Talati & Co. appointed as Cost Auditor for FY 2026-27.
Interim dividend of Rs. 1 per equity share declared for FY 2025-26.
Increase in gratuity liability due to new Labour Codes.
Impact of new Labour Codes on gratuity liability.
Proposed merger of a subsidiary pending NCLT sanction.
Approved sub-division of equity shares to enhance market liquidity.
Alteration of Capital Clause in Memorandum of Association.

Corporate Governance

Auditors adhere to the Code of Ethics issued by ICAI.
Appointments and changes approved by Nomination and Remuneration Committee.
Audit Committee and Nomination and Remuneration Committee are active.

Management Discussion & Analysis

Future Strategy

Share sub-division to enhance affordability and liquidity.
Aims to increase market participation, especially from retail investors.
Proposed merger of Medulla Healthcare Private Limited pending NCLT sanction.

Operational Focus Areas

Strengthening operational efficiency and patient care delivery.
Process optimization and quality assurance are key focus areas.

Performance Drivers

Revenue from operations increased for both consolidated and standalone.
Net profit remained stable year-on-year.
Significant capital expenditure drives asset growth.

Risk Control Measures

Compliance with SEBI Listing Regulations and accounting standards.
Unmodified audit opinions from statutory auditors.

Critical Risks

Increased gratuity liability due to new Labour Codes.
Reliance on other auditors for subsidiaries and partnership firms.